Sarbesh Kumar Jha

Department of Interventional cardiology, Koshi Hospital, Biratnagar, Nepal

Publications

  • Review   
    Cardiovascular diseases in COVID -19 : A Narrative Review
    Author(s): Sarbesh Kumar Jha, Deepak Sigdel and Atul Dwivedi*

    COVID-19 was reported in late December 2019. Since then it has been announced as a global pandemic affecting more than 200 countries, with an unwanted effect on social, economic and public health. Cardiovascular disease has been reported in COVID -19 patients. Most probably, cardiovascular complications of COVID-19 are the combination of direct viral injury and host’s immune response resulting in vascular inflammation and myocardial inflammation. Additionally, COVID-19 can cause cardiac complications through several ways such as increased release of Cytokines causes indirect cardiac injury direct invasion of cardiac myocytes. Respiratory damage causes hypoxia, supply - demand mismatched in myocardial tissue, followed by oxidative stress and injury in cardiomyocytes. Cardiac manifestations of COVID-19 include cardiogenic shock, fatal Arrhythmias, myocarditis and acute heart failu.. Read More»

    Abstract HTML PDF